Macrophage tumoricidal activity induced by human C-reactive protein.
Purified C-reactive protein (CRP), the prototypical acute phase reactant of humans, activated inflammatory mouse macrophages to a tumoricidal state. The activation by CRP was not due to small amounts of contaminating lipopolysaccharide. CRP at 10 micrograms/ml induced significant tumoricidal capacity in resident macrophages; the mouse macrophage cell lines PU5 1.8, RAW 264.7, and J774; as well as elicited macrophages from two lipopolysaccharide nonresponder strains, C3H/HeJ and C57BL/10Sc. Macrophages obtained from bone marrow-derived monocytes grown in vitro and exudate macrophages depleted of T-cells were also readily activated by microgram/ml amounts of CRP. Removal of CRP from culture medium using anti-CRP antibodies or phosphorylcholine-agarose beads abrogated the induction of tumoricidal activity. CRP acted independently of both lymphokines and lipopolysaccharide. Therefore, CRP may serve as a physiologically relevant macrophage activator, contributing to the heightened nonspecific host resistance associated with the early stages of a systemic inflammatory response.
D000818:Animals; D002097:C-Reactive Protein / Q000494:pharmacology*; D002460:Cell Line; D003602:Cytotoxicity, Immunologic / Q000187:drug effects; D005260:Female; D006801:Humans; D008070:Lipopolysaccharides / Q000494:pharmacology; D008222:Lymphokines / Q000494:pharmacology; D008262:Macrophage Activation / Q000187:drug effects*; D051379:Mice; D008815:Mice, Inbred Strains; D009369:Neoplasms / Q000276:immunology*; D011112:Polymyxin B / Q000494:pharmacology; D013601:T-Lymphocytes / Q000502:physiology
D008070:Lipopolysaccharides; D008222:Lymphokines; D002097:C-Reactive Protein; D011112:Polymyxin B